The International Iberian Nanotechnology Laboratory- INL is an Intergovernmental Organisation created to foster interdisciplinary research in Nanotechnology and Nanoscience. Aiming to become a vital part of Europe’s scientific area, INL provides a high-tech research environment addressing major challenges in nanomedicine, nanotechnology applied to environmental & food control nanoelectronics, and nanomachines and molecular manipulation at nanoscale.
NANOMOL is a research group with wide expertise and recognized excellence in the synthesis, processing and study of molecular and polymeric materials with chemical, electronic, magnetic and biomedical properties. We continuously generate new knowledge in our basic and applied research projects regarding the micro and nano structuring of molecular materials. We offer this knowledge to improve the properties of products manufactured in diverse sectors, such as chemicals, pharmaceuticals and electronics, thereby contributing to increasing their added value.
Since its foundation in 2006, BioNanoNet has promoted innovative research by supporting cooperation, creating synergies in Austria and initiating national and international research projects in the fields of medical and pharmaceutical research, nanomedicine, nanotoxicology and sensor technology. The success of the BioNanoNet stems from the “network platform” and the coordination among leading key players from this platform, which is the engine that drives interdisciplinary and innovative processes in these research areas.
Manhattan Scientifics, Inc. (OTCQB: MHTX), is focused on commercialization of technologies in the nano-medicine space. The company works among the brilliant minds and groundbreaking ideas in the fertile ground of New Mexico – home to two national laboratories, and one of the nation’s highest concentrations of PhD scientists. These technologies are scientifically advanced, but are rarely ready for commercialization.
Nanobiotix, pioneer and leader in nanomedicine has developed a revolutionary concept dedicated to the local treatment of cancer. Nanobiotix is focused on the development of NanoXray, a pipeline of patented products, which are based on a physical mechanism of action: nanoparticles interact with X-rays and maximize the effect of radiotherapy within tumor cells. NanoXray products enhance the radiotherapy efficacy in the tumor without increasing healthy tissues damages.
The International Association of Nanotechnology (IANT), is a non-profit organization with the goals to foster scientific research and business development in the areas of Nanoscience and Nanotechnology for the benefit of society.
IMM work on the two development pathways-chemical (supramolecular) and physical (scanning probe) — is the most advanced theoretical work done to date, and is published in the most highly-regarded journals in those fields.
CytoViva® is a leading provider of advanced optical microscopy and hyperspectral imaging technologies. These technologies have been specifically designed for nanomaterials, nanomedicine and life science related research. The CytoViva Hyperspectral Imaging System evolved from technology originally developed for aerial based imaging applications within Department of Defense and NASA.